There is no reliable evidence that CBN (cannabinol) lowers blood pressure. Despite growing interest in CBN as a sleep aid and wellness supplement, its specific effects on blood pressure have not been studied in any published human clinical trial. What we know about cannabinoids and blood pressure comes mostly from research on THC and whole-plant cannabis, and those findings don’t automatically apply to CBN.
What the Research Actually Shows
A 2023 review in Therapeutic Advances in Chronic Disease noted that the molecular targets of CBN suggest a potentially protective impact on the heart and blood vessels, but immediately followed that observation with a critical caveat: the lack of animal or human studies creates “a huge knowledge gap” around CBN’s cardiovascular effects. In plain terms, scientists have reason to think CBN interacts with receptors involved in heart and blood vessel function, but nobody has tested what happens to blood pressure when people take it.
One ongoing clinical trial, the CUPID study published in BMJ Open, is testing CBN at doses of 30 mg and 300 mg for insomnia. That study does measure blood pressure at multiple points during each session. Early safety data from preliminary studies found no adverse changes in heart rate, blood pressure, body temperature, or respiratory rate. That’s encouraging for safety, but “no adverse changes” is not the same as “lowers blood pressure.” It simply means CBN didn’t cause worrying spikes or drops at the doses tested.
Why CBN Gets Confused With Other Cannabinoids
Much of the confusion comes from lumping all cannabinoids together. CBN is a breakdown product of THC. As THC in harvested cannabis ages and oxidizes, it slowly converts into CBN. Because CBN comes from THC, people sometimes assume it behaves similarly in the body. It doesn’t, at least not in predictable ways.
THC and whole-plant cannabis have well-documented effects on blood pressure. Acute cannabis use typically raises heart rate by 20% to 100% for two to three hours, often with a slight increase in blood pressure while lying down. At higher doses, cannabis can cause postural hypotension, a sudden drop in blood pressure when standing that leads to dizziness or fainting. This effect is more pronounced in people who already have high blood pressure and appears to result from widening of blood vessels. Chronic cannabis users, over time, tend to see their heart rate decrease and orthostatic hypotension disappear as the body adapts.
These effects are driven primarily by THC acting on CB1 receptors in the brain and nervous system. CBN binds to the same receptors but much more weakly, roughly one-tenth the potency of THC. So even if THC’s blood pressure effects are partly relevant, you can’t scale them down and assume CBN does the same thing at a smaller magnitude. The biology is more complicated than that.
How Cannabinoids Influence Blood Pressure
Cannabinoids affect blood pressure through CB1 receptors located in parts of the brainstem that regulate cardiovascular function. When these receptors are activated in certain brain regions, they can increase sympathetic nerve activity, raise levels of norepinephrine (a stress hormone), and push blood pressure up. In other brain regions, activating the same type of receptor enhances the body’s natural blood-pressure-lowering reflex by reducing the release of a chemical messenger called GABA.
This is why cannabinoids can both raise and lower blood pressure depending on the dose, the route of administration, and where in the nervous system they act. The net effect in any given person is hard to predict, even for well-studied cannabinoids like THC. For CBN, where targeted cardiovascular research simply hasn’t been done, predictions are even less reliable.
The Sleep Connection
One indirect route by which CBN could theoretically affect blood pressure is through sleep. Poor sleep and insomnia are linked to higher blood pressure over time, and CBN is most commonly marketed as a sleep supplement. If CBN genuinely improves sleep quality, that could have downstream benefits for cardiovascular health. But this is speculative. The CUPID trial measuring CBN’s effects on insomnia hasn’t published results yet, so even the sleep claim remains unproven in rigorous research.
Potential Interactions With Blood Pressure Medications
If you take medication for high blood pressure, the interaction risk may be more important than whether CBN lowers blood pressure on its own. A study in the AAPS Journal found that nearly all cannabinoids tested, CBN included, inhibit a liver enzyme called CYP2C9. This enzyme is responsible for breaking down several common medications. When a supplement blocks this enzyme, it can cause those medications to build up in your bloodstream to higher-than-intended levels.
Some blood pressure medications, particularly certain types that are metabolized through this pathway, could be affected. The researchers noted that further investigation is justified for any drug with a narrow therapeutic index, meaning medications where even small changes in blood levels can cause problems. If you’re on blood pressure medication and considering CBN, this enzyme interaction is worth discussing with your pharmacist or prescriber.
The Bottom Line on CBN and Blood Pressure
CBN has not been shown to lower blood pressure in any human study. The broader cannabinoid family does interact with cardiovascular regulation in complex ways, sometimes raising and sometimes lowering blood pressure depending on the specific compound, dose, and context. But applying those findings to CBN specifically requires a leap the science hasn’t made yet. The most honest answer right now is that nobody knows what CBN does to blood pressure, and any supplement company claiming otherwise is getting ahead of the evidence.